
Phio Pharmaceuticals
(NASDAQ) PHIO
Phio Pharmaceuticals Financials at a Glance
Market Cap
$14.87M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.70M
EPS (TTM)
$-1.50
P/E Ratio
-0.85
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$1.28
Volume
2,791
Open
$1.26
Price
$1.28
Volume
2,791
Open
$1.26
Previous Close
$1.28
Daily Range
$1.26 - $1.30
52-Week Range
$0.81 - $4.19
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$1.28
Volume
2,791
Open
$1.26
Previous Close
$1.28
Daily Range
$1.26 - $1.30
52-Week Range
$0.81 - $4.19
PHIO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Phio Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Robert J. Bitterman, Sr., MBA
Website
www.phiopharma.comHeadquarters
Marlborough, MA 01752, US
PHIO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-70%
Return on Capital
-44%
Return on Assets
-40%
Earnings Yield
-1.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.87M
Shares Outstanding
11.62M
Volume
2.79K
Short Interest
0.00%
Avg. Volume
3.78M
Financials (TTM)
Gross Profit
$3.00K
Operating Income
$9.22M
EBITDA
$9.22M
Operating Cash Flow
$7.98M
Capital Expenditure
$12.00K
Free Cash Flow
$7.99M
Cash & ST Invst.
$21.03M
Total Debt
$0.00
Phio Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$14.87M
N/A
Market Cap/Employee
$2.97M
N/A
Employees
5
N/A
Net Income
$2.37M
-45.8%
EBITDA
$2.53M
-55.8%
Quarterly Fundamentals
Net Cash
$21.03M
+290.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-40.48%
N/A
Return on Invested Capital
-43.80%
N/A
Free Cash Flow
$2.08M
-51.5%
Operating Cash Flow
$2.08M
-51.6%
